Literature DB >> 25105204

Impact of polymers on the precipitation behavior of highly supersaturated aqueous danazol solutions.

Matthew J Jackson1, Scott J Toth, Umesh S Kestur, Jun Huang, Feng Qian, Munir A Hussain, Garth J Simpson, Lynne S Taylor.   

Abstract

The phase behavior of supersaturated solutions of a relatively hydrophobic drug, danazol, was studied in the absence and presence of polymeric additives. To differentiate between phase separation to a noncrystalline phase and phase separation to a crystalline phase, an environmentally sensitive fluorescent probe was employed. Induction times for crystallization in the presence and absence of polymeric additives were studied using a combination of ultraviolet and fluorescence spectroscopy. It was found that, when danazol was added to aqueous media at concentrations above the amorphous solubility, liquid-liquid phase separation was briefly observed prior to crystallization, resulting in a short-lived, drug-rich noncrystalline danazol phase with an initial size of around 500 nm. The addition of polymers was found to greatly extend the lifetime of the supersaturated two phase system, delaying the onset of crystallization from a few minutes to a few hours. Below a certain threshold danazol concentration, found to represent the amorphous solubility, only crystallization was observed. Thus, although the addition of polymers was unable to prevent danazol from precipitating once a threshold concentration was exceeded, they did inhibit crystallization, leading to a solution with prolonged supersaturation. This observation highlights the need to determine the structure of the precipitating phase, since it is linked to the resultant solution concentration time profile.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25105204     DOI: 10.1021/mp500201s

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  12 in total

1.  Classification of the crystallization tendency of active pharmaceutical ingredients (APIs) and nutraceuticals based on their nucleation and crystal growth behaviour in solution state.

Authors:  Sneha Rathi; Rahul B Chavan; Nalini R Shastri
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

2.  Leveraging Colloidal Aggregation for Drug-Rich Nanoparticle Formulations.

Authors:  Ahil N Ganesh; Jennifer Logie; Christopher K McLaughlin; Benjamin L Barthel; Tad H Koch; Brian K Shoichet; Molly S Shoichet
Journal:  Mol Pharm       Date:  2017-05-19       Impact factor: 4.939

Review 3.  Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges.

Authors:  Jinjiang Li; Dhaval Patel; George Wang
Journal:  AAPS J       Date:  2016-11-28       Impact factor: 4.009

4.  Characterization of Phase Transformations for Amorphous Solid Dispersions of a Weakly Basic Drug upon Dissolution in Biorelevant Media.

Authors:  Ahmed Elkhabaz; Sreya Sarkar; Garth J Simpson; Lynne S Taylor
Journal:  Pharm Res       Date:  2019-10-30       Impact factor: 4.200

5.  Characterization of Supersaturated Danazol Solutions - Impact of Polymers on Solution Properties and Phase Transitions.

Authors:  Matthew J Jackson; Umesh S Kestur; Munir A Hussain; Lynne S Taylor
Journal:  Pharm Res       Date:  2016-02-18       Impact factor: 4.200

6.  Stable Colloidal Drug Aggregates Catch and Release Active Enzymes.

Authors:  Christopher K McLaughlin; Da Duan; Ahil N Ganesh; Hayarpi Torosyan; Brian K Shoichet; Molly S Shoichet
Journal:  ACS Chem Biol       Date:  2016-01-15       Impact factor: 5.100

7.  Colloidal aggregation: from screening nuisance to formulation nuance.

Authors:  Ahil N Ganesh; Eric N Donders; Brian K Shoichet; Molly S Shoichet
Journal:  Nano Today       Date:  2018-03-10       Impact factor: 20.722

8.  Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.

Authors:  Yuejie Chen; Shujing Wang; Shan Wang; Chengyu Liu; Ching Su; Michael Hageman; Munir Hussain; Roy Haskell; Kevin Stefanski; Feng Qian
Journal:  Pharm Res       Date:  2016-06-09       Impact factor: 4.200

Review 9.  Drug-Rich Phases Induced by Amorphous Solid Dispersion: Arbitrary or Intentional Goal in Oral Drug Delivery?

Authors:  Kaijie Qian; Lorenzo Stella; David S Jones; Gavin P Andrews; Huachuan Du; Yiwei Tian
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

10.  Effect of supersaturation on the oral bioavailability of paclitaxel/polymer amorphous solid dispersion.

Authors:  Linlin Miao; Yuheng Liang; Wenli Pan; Jingxin Gou; Tian Yin; Yu Zhang; Haibing He; Xing Tang
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.